Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Carlyle Group Inc. - Common Stock (NQ: CG )

38.79 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about The Carlyle Group Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Carlyle’s Next Takeover Target Should Be Itself
With public shareholders laser-focused on steady fee income and disfavoring lumpy lucre from deals, Schwartz’s company unsurprisingly trades at a discount to peers. 
Via Talk Markets
Friday Is Your Last Chance To Buy Carlyle Group Before The Dividend Payout
Via Benzinga
Acentra Health Awarded New Contract Supporting Utilization Management and Assessment Services for West Virginia Medicaid
Award builds on company’s 23-year state partnership to accelerate better health outcomes for Medicaid members 
From Acentra Health
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About Carlyle Group
Via Benzinga
Private Equity Firm Carlyle Q3 Revenue Misses Consensus On Lower Fee Related Earnings
The Carlyle Group Inc (NASDAQ: CG) reported  
Via Benzinga
Earnings Preview: Carlyle Group
Via Benzinga
Analyst Expectations for Carlyle Group's Future
Via Benzinga
What 10 Analyst Ratings Have To Say About Carlyle Group
Via Benzinga
Acentra Health’s eQSuite and IMEDECS Applications Achieve HITRUST Risk-based, 2-year Recertification Demonstrating Highest Level of Information Protection Assurance
HITRUST Risk-based, 2-year (r2) Certification validates Acentra Health is committed to strong cybersecurity and meeting key regulations to protect sensitive data 
From Acentra Health
Via GlobeNewswire
Deutsche Bank Maintains Buy Rating for Carlyle Group: Here's What You Need To Know
Via Benzinga
U.S. Department of Veterans Affairs Awards Acentra Health $52.3M Financial Services Center Contract for Claims Adjudication, Provider Access, Data Analytics and Visualization
From Acentra Health
Via GlobeNewswire
Analyst Ratings for Carlyle Group
Via Benzinga
SEC Collects Thousands Of Messages In Wall Street Messaging App Investigation
The U.S. Securities and Exchange Commission (SEC) has escalated its investigation into Wall Street's use of private messaging applications. 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Carlyle Group Stock Scores Rising Relative Strength Rating
Carlyle Group stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 75. 
Via Investor's Business Daily
10 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
What's Going On With BlackBerry Stock Monday?
BlackBerry Limited (NYSE: BB) stock is trading higher Monday amid its launch of a new series of BlackBerry Radar devices – H2M IS – for hazardous materials carriers. 
Via Benzinga
Acentra Health Awarded Contract Extension Overseeing Utilization Management Services for Florida Medicaid
Award affirms URAC-accredited company's role as a vital partner to the state for accelerating better health outcomes 
From Acentra Health
Via GlobeNewswire
Tuesday Talk: Like A Carousel
Via Talk Markets
How To Play The Instacart IPO
If the Instacart deal goes off without a hitch, private equity companies will know that there is plenty of investor appetite for new stocks. We can then expect a wide assortment of new IPO deals to be... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
BlackBerry Just Got A Potential Takeover Offer - What's Going On?
BlackBerry Limited (NYSE: BB) stock is trading higher Friday amid reports of a possible takeover offer from private equity firm Veritas Capital, a Carlyle Group (NASDAQ: CG) company.  
Via Benzinga
This Billionaire Investor Loves Bitcoin. But Is It Right for You?
Greater institutional adoption of Bitcoin could lead to future price gains, says billionaire investor David Rubenstein. 
Via The Motley Fool
Carlyle Takes Significant Minority Stake In Singapore-Based Engineering Services Firm Quest Global
The Carlyle Group Inc (NASDAQ: CG) inked a definitive deal to acquire a significant minority stake in Quest Global  
Via Benzinga
Why iRobot Stock Fell 11.6% Last Month
Amazon's $1.7 billion buyout bid shrank to $1.4 billion as the robotic vacuum cleaner veteran took on more debt. But investors worry that the deal could fall through on regulatory concerns. 
Via The Motley Fool
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
FDIC Launches Mega Sale: Signature Bank's $18.5B Loan Portfolio On The Market
Via Benzinga
IRBT Stock Sinks 12% as Amazon Lowers iRobot Price
Amazon’s lowered price adjustment for buying out iRobot amid the latter’s financing facility agreement sent IRBT stock tumbling down. 
Via InvestorPlace
Tesla's New $1,670 Electric Quad Bike for Kids, Meta Seeks To Release Commercial AI Model, YouTube Stars' Energy Drink Under FDA Review: Today's Top Stories
Financial Times Meta Platforms Seeks To Launch Commercial Version Of Its Artificial Intelligence Model 
Via Benzinga
Owners Of McDonald's China Seek Partial Exit: Report
Carlyle Group Inc (NASDAQ: CG) and Trustar Capital reportedly plan to exit part of their stakes in McDonald's Corp (NYSE: MCD) operations in Hong Kong and mainland China.  
Via Benzinga
Jack Ma-Backed Ant Group To Buy Back Shares At 70% Lower Valuation Than At IPO
Billionaire Jack Ma-backed Ant Group Co. is planning to buy back as much as 7.6% of shares to retain skilled individuals and offer an exit to investors who have been impacted by the company's regulat 
Via Benzinga
Carlyle and Stellex Complete Sale of Titan to an Affiliate of Lone Star Funds
From Stellex Capital Management
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.